Department of Clinical Laboratory, No. 3 People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.
Int J Biochem Cell Biol. 2012 Sep;44(9):1465-72. doi: 10.1016/j.biocel.2012.05.015. Epub 2012 May 27.
MicroRNAs (miRNAs) are strongly implicated in carcinogenesis, but their specific roles in the major cancers have yet to be fully elucidated.
The expression levels of miR-139 in colorectal carcinoma and paired normal tissues were examined using real-time PCR assays. Potential functions of miR-139 were evaluated in colorectal carcinoma cell lines (SW480, SW620, LS174 T, and HCT116) using miR-139 mimics, anti-miR-139, and siRNA RAP1B.
In this study, we determined that miR-139 is down-regulated in colorectal carcinoma (CRC) tissues. Lower miR-139 expression correlates with more advanced CRC and lower overall survival of patients with CRC. The ectopic expression of miR-139 in human CRC cells decreased cell growth and tumorigenicity, whereas the silencing of miR-139 promoted cell growth. Mechanistic studies revealed that miR-139 repressed the activity of a reporter gene fused to the 3'-untranslated region of RAP1B, whereas miR-139 silencing up-regulated the expression of the reporter gene. RNAi-mediated knockdown of RAP1B phenocopied the antiproliferative effect of miR-139, whereas the overexpression of RAP1B blocked miR-139-mediated antiproliferative effects in CRC cells.
Taken together, these results demonstrated that miR-139 decreases proliferation by directly targeting RAP1B, defining miR-139 as a new putative tumour suppressor miRNA in CRC.
微小 RNA(miRNAs)在癌症发生中起着重要作用,但它们在主要癌症中的具体作用尚未完全阐明。
使用实时 PCR 检测 miR-139 在结直肠癌及配对正常组织中的表达水平。通过 miR-139 模拟物、抗 miR-139 和 siRNA RAP1B 在结直肠癌细胞系(SW480、SW620、LS174 T 和 HCT116)中评估 miR-139 的潜在功能。
在本研究中,我们确定 miR-139 在结直肠癌(CRC)组织中下调。较低的 miR-139 表达与 CRC 的更晚期和 CRC 患者的总生存率降低相关。在人 CRC 细胞中外源性表达 miR-139 可降低细胞生长和致瘤性,而 miR-139 的沉默则促进了细胞生长。机制研究表明,miR-139 抑制了与 RAP1B 3'-非翻译区融合的报告基因的活性,而 miR-139 沉默则上调了报告基因的表达。RAP1B 的 RNAi 介导的敲低可模拟 miR-139 的抗增殖作用,而 RAP1B 的过表达则可阻断 miR-139 在 CRC 细胞中的抗增殖作用。
综上所述,这些结果表明 miR-139 通过直接靶向 RAP1B 降低增殖,将 miR-139 定义为 CRC 中的一种新的潜在肿瘤抑制 miRNA。